CD34 and acute myeloid leukemia: Therefore, to assess the effect of AML derived-EVs on CD34+ SDF-1 mediated migration, firstly, we evaluated CXCR4 receptor expression on CD34+ cells treated with EVs observing a significant decrease of its levels on EV treated cells respect to control (Figures 7A, B).